Fact CheckerSign in

NCT05964777Completed

rTMS-tACS Stimulation on Improving Cognitive Function in Bipolar Disorder

Efficacy and Safety of rTMS-tACS Stimulation on Improving Cognitive Function in Bipolar Disorder: a Randomized, Double-blind, Sham Controlled Study

Source: ClinicalTrials.gov · Last updated 28 May 2026

Brief summary (registry, in English)

Based on the individualized positioning technology of diffusion tensor imaging (DTI), the purpose of this study is to explore a new stimulation target and protocol for the treatment of bipolar disorder in remission through the repetitive transcranial magnetic stimulation(rTMS) and transcranial alternating current stimulation(tACS)under neuronavigation,verify whether there is abnormal functional connectivity and structural connections between the dorsolateral prefrontal cortex (dlpfc) and the dorsal anterior cingulate gyrus (dacc) related to cognitive impairment in bipolar disorder in remission, which will contribute to further understand the relevant neural pathway and mechanism.

Status (registry)
Completed
Study type
Interventional
Enrollment
116 (actual)
First submitted
20 Jul 2023
Start date
1 Jul 2023
Primary completion date
3 Jul 2024
Lead sponsor
First Affiliated Hospital of Zhejiang University
NCT number
NCT05964777

What you commit to

  • Study type: Interventional
  • Participants enrolled: 116
  • From 1 Jul 2023 to the primary completion date, 3 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Drug, alcohol or other psychoactive substance abusers;

Other illness

  • History of severe somatic or brain organic diseases and craniocerebral trauma;

Other

  • Abnormal brain structure or any MRI contraindications were found by magnetic resonance examination;
  • Those who do not cooperate or cannot effectively complete the experiment;
  • Pregnant, lactating or planned pregnancy;
  • ECT or rTMS or tACS treatment was performed within six months.

Who the study is looking for

  • 1\. Age 14-45 years old, regardless of gender\] 2.Meet DSM-V diagnostic criteria for bipolar depressive in remission 3.Young Mania Rating Scale (YMRS) ≤ 6 points; 4.Hamilton Depression Scale(HAMD-17)≤7 points; 5.Cognitive deficit questionnaire PDQ≥17 points; 6.Han nationality, right-handed; 7.More than 9 years of education.

Age in the registry: 14 years to 45 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Psychiatry, First Affiliated Hospital of Zhejiang University
Coordinator of this site? Confirm its status
HangzhouChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.